packageTeniposide

teniposide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Teniposide is an anticancer drug used to treat acute lymphocytic leukemia and other lymphoblastic leukemias, as well as small cell lung cancer. It is an approved antineoplastic agent, a podophyllotoxin derivative that acts as a topoisomerase II inhibitor, but it is not authorised in the European Union and is used only in limited settings.

Summary written by glm-5.3-flash from Wikidata Q417555 and the WHO ATC classification; not checked by a person.

name:teniposide
ATC codes:L01CB02
DrugBank:DB00444
PubChem CID:452548
ChEBI:75988
Wikidata:Q417555
formula:C32H32O13S
molar mass:656.655 g/mol (PubChem CID 452548)
logP:1.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown